Celcuity has secured FDA approval for gedatolisib, now branded as Revtorpyk, marking a significant milestone in the treatment of hormone receptor-positive, HER2-negative breast cancer. The regulator approved Revtorpyk specifically for previously treated
Karan Monga is a Supply Chain and Operations Management expert who has made significant contributions to the industry, particularly during the challenging times of the COVID-19 pandemic. His journey from founding his own
MoreHome cosiness has always been the key to the success and peace of mind of any family. Every person strives to emphasise their own individuality with the help of various elements of
More
